Parasiticides
A selection of BSAVA resources related to parasiticide treatment, tolerance of and resistance. Cover image of a lungworm is taken from the BSAVA Manual of Canine and Feline Clinical Pathology.
Updated 2025.
Collection Contents
11 results
-
-
BSAVA PetSavers research
A One Health perspective on pet parasiticides 
A ‘One Health’ approach to the control of pet parasites considers the broader implications of parasiticide use, balancing animal, human and environmental health. With funding support from a BSAVA PetSavers Clinical Research Project grant, Rosemary Perkins is investigating imidacloprid emissions from collar-treated dogs to assess the significance of this pollution pathway. In this article Dr Perkins explains more about the study and how this research fits into the broader picture of evidence-based and responsible pet parasiticide use.
-
-
-
Companion interview
Flea product residues – health and safety considerations 
Spot-on flea product residues washed off canine coats are a threat to the health of the complex invertebrate communities living in the UK’s river systems, a multidisciplinary research team has found. Could veterinary staff also be at risk when handling patients treated with these agents? Veterinary surgeon Andrew Prentis told John Bonner why he believes this is an important question and one that must be answered.
-
-
-
Focus on…
Responsible usage of ectoparasiticides in small animal practice 
Martin Whitehead, from Chipping Norton Veterinary Hospital and Rosemary Perkins, from the University of Sussex, explore what is known, and not known, about the benefits and risks of companion animal ectoparasiticides, and what responsible, risk-based usage of these products may entail.
-
-
-
Will POM-V anthelmintics combat drug resistance?
Drug resistance 
Ian Wright of Mount Vets and Head of ESCCAP UK & Ireland, discusses whether small animal anthelmintics should be made POM-V to reduce the risk of drug resistance.
-